Bessemer Group
MEDP icon

Bessemer Group’s Medpace MEDP Stock Holding History

Bessemer Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150M Sell
282,897
-2,534
-0.9% -$1.17M 0.21% 129
2026
Q1 		$137M Sell
285,431
-31,609
-10% -$16.2M 0.22% 115
2025
Q4 		$178M Sell
317,040
-24,877
-7% -$14.1M 0.27% 93
2025
Q3 		$176M Sell
341,917
-165,755
-33% -$72.4M 0.27% 93
2025
Q2 		$159M Sell
507,672
-74,597
-13% -$22.4M 0.26% 101
2025
Q1 		$177M Buy
582,269
+6,225
+1% +$2.09M 0.32% 77
2024
Q4 		$191M Buy
576,044
+75,275
+15% +$25.5M 0.31% 77
2024
Q3 		$167M Buy
500,769
+16,279
+3% +$6.18M 0.28% 101
2024
Q2 		$200M Buy
484,490
+89,656
+23% +$35.5M 0.35% 71
2024
Q1 		$160M Buy
394,834
+6,137
+2% +$2.16M 0.29% 101
2023
Q4 		$119M Buy
388,697
+106,907
+38% +$28.9M 0.23% 118
2023
Q3 		$68.2M Buy
281,790
+281,756
+828,694% +$72.1M 0.15% 165
2023
Q2 		$8K Buy
34
+21
+162% +$4.36K ﹤0.01% 1700
2023
Q1 		$2K Sell
13
-16
-55% -$3.31K ﹤0.01% 1816
2022
Q4 		$6K Sell
29
-31
-52% -$6.19K ﹤0.01% 1528
2022
Q3 		$10K Buy
60
+9
+18% +$1.44K ﹤0.01% 1553
2022
Q2 		$8K Hold
51
– – ﹤0.01% 1419
2022
Q1 		$8K Hold
51
– – ﹤0.01% 1431
2021
Q4 		$11K Hold
51
– – ﹤0.01% 1398
2021
Q3 		$10K Buy
+51
New +$9.3K ﹤0.01% 1377
2020
Q3 		– Sell
-19,700
Closed -$1.83M – 1538
2020
Q2 		$1.83M Buy
19,700
+4,800
+32% +$408K 0.01% 510
2020
Q1 		$1.09M Buy
+14,900
New +$1.29M ﹤0.01% 585
2019
Q4 		– Sell
-199
Closed -$17K – 1718
2019
Q3 		$17K Buy
+199
New +$15K ﹤0.01% 1423

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bessemer Group's MEDP Position: Q2 2026 in Review

Bessemer Group reduced its Medpace (MEDP) stake by 0.89% in Q2 2026, selling an estimated $1.17M and leaving 282,897 shares worth $150M. The position accounts for 0.21% of the portfolio, ranked #129.

Bessemer Group first reported a position in MEDP in Q3 2019 and has held it in 23 quarters since. The position peaked at $200M in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bessemer Group held 282,897 shares of Medpace worth $150M as of Q2 2026.
  • Bessemer Group sold 2,534 Medpace shares in Q2 2026, an estimated $1.17M.
  • Medpace made up 0.21% of Bessemer Group's portfolio in Q2 2026, its #129 holding.
  • Bessemer Group first reported a position in Medpace in Q3 2019 and has held it in 23 quarters since.
  • Bessemer Group's Medpace position peaked at $200M in Q2 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.